Webinar 2024.01

Current status of PSMA-targeted imaging and therapy 

Date: March 26, 2024
Time: 18:00 (CET)
Speaker: Lena Unterrainer, Munich/Germany

Description

The aim of this webinar is to review the current status of PSMA-targeted imaging and therapy. The basics of the theranostic concepts will be discussed in the context of PSMA-targeted theranostics. In the course of the talk, the speaker will give a future outlook on potential new indications for PSMA-targeted theranostics.

Learning objectives

To understand the basic principles of theranostics
To understand the current status of PSMA-targeted theranostics
To become familiar with potential new indications for PSMA-targeted theranostics

About the speaker: Lena Unterrainer

PD Dr. Lena Unterrainer, MHBA is an attending physician in the Department of Nuclear Medicine, LMU Munich. She is specialized in uro-oncology and novel theranostic approaches.

Webinar 2024.02

PCCT – New Insights into Cardiac Imaging

Date: April 16, 2024
Time: 18:00 (CET)
Speaker: Isabelle Ayx (Munich, Germany)

Description

Join us for an upcoming webinar exploring the advanced technology of Photon-Counting Computer Topography (PCCT) and its profound impact on cardiac CT imaging. PCCT’s superior spatial and temporal resolution, along with its enhanced signal-to-noise ratio, are pivotal in advancing cardiac imaging capabilities. This webinar will delve into the revolutionary implications of PCCT for cardiac imaging, highlighting its potential to significantly improve diagnostic accuracy and patient outcomes. Additionally, we’ll explore the future integration of artificial intelligence (AI) techniques, including hemodynamic flow measurements in CT and radiomics analysis, with the overarching goal of identifying imaging biomarkers. Don’t miss this opportunity to gain insights into the cutting-edge innovations shaping the future of cardiovascular imaging.

Learning objectives

To understand the basic principles and technological approaches of photon-counting detector computed tomography (PCCT)
To become familiar with the development of cardiac CT imaging through the novelty of PCCT in daily routine
To learn about potential new perspectives of AI using PCCT in cardiac imaging in future.

About the speaker: Dr. Isabelle Ayx

As a specialist in radiology at the Clinic for Radiology and Nuclear Medicine at the University Hospital in Mannheim, PD Dr. Isabelle Ayx assumes a dual role as the site manager in Wolfratshausen for RDTM. Holding these positions highlights her dedication to advancing medical imaging technologies and research – and implementation in daily routine in an inpatient and outpatient setting. Within the University Hospital in Mannheim, she serves as the scientific head of the ISO-certified Center for Cardiovascular Imaging. Since the installation of the Photon-Counting Computer Topographer (PCCT) in 2021, Dr. Isabelle Ayx has been at the forefront of leading cardiovascular research using this state-of-the-art technology. Through the PC3 Consortium, comprising the University Hospitals of Mannheim, Freiburg, and Tübingen, multicenter studies have showcased the clinical advantages of PCCT in cardiac imaging. Dr. Ayx’s endeavors underscore the significance of collaboration and innovation in advancing medical imaging for enhanced patient care.

Webinar 2024.10

Multimodal characterization of cachexia in patients with lung cancer

Date: October 24, 2024
Time: 18:00 (CET)
Speaker: Armin Frille (Leipzig, Germany)

Description

Cachexia is defined as a complex metabolic syndrome characterized by the loss of body weight, which negatively affects quality of life and survival in lung cancer patients. This devastating disorder occurs in up to 50% of all cancer patients and is characterised by nutritional impairment, weakness, and wasting, and in turn affects treatment success and quality of life.

Even though diagnostic criteria for cancer cachexia have been established, the success of management of cachexia is often hampered by its complex pathophysiology. Therefore, body composition assessment, for instance by means of PET/CT, may help understand complex interaction between lung cancer cells, muscle and adipose tissues.

The webinar will be a 45 min lecture by Dr. Armin Frille with 15 minutes of discussion, which will for one cover the basics of cachexia with particular focus on patients with lung cancer. The lecture will then showcase selected results from clinical and pre-clinical research on PET/CT imaging, brown adipose tissue, adipokines, and their interactions in lung cancer.

Learning objectives

Cachexia in lung cancer significantly impairs body composition, and survival
Brown adipose tissue activation is associated with cachexia, poor survival and with a specific adipokine signaling
Adipose tissues impairs anti-tumor efficacy under co-culture conditions
Region-specific glucose metabolism in the brain predicts cachexia in in lung cancer patients using FDG-PET/CT
Metabolic inter-organ connectivity help identify lung cancer patients with cachexia, but not early-onset

About the speaker: Armin Frille

Dr. Armin Frille is an internist, pulmonologist, consultant, and clinician scientist at the Department of Respiratory Medicine at University Hospital in Leipzig, Germany. His research focuses primarily on lung cancer, cachexia and imaging modalities.

https://orcid.org/0000-0003-2843-3863

Webinar 2024.10

Hybrid imaging in neuroendocrine tumors

Date: October 29, 2024
Time: 18:00 (CET)
Speaker: Freba Grawe (Heidelberg, Germany)

Description

The aim of this webinar is to provide an overview of the current status of hybrid imaging in neuroendocrine tumors (NET). The basics of somatostatin receptor targeted imaging and therapy in NET will be briefly outlined. The role of structured reporting with a focus on the SSTR-RADS and NETPET score and their impact on diagnosis, therapy decision, and outcome in NET patients will be discussed.

Learning objectives

To understand the principle of somatostatin receptor targeted imaging and therapy in NET
To understand the current role of structured reporting in NET
To understand the impact of structured reporting on clinical decision making in NET

Webinar 2024.11

Clinical applications of Dual-energy CT

Date: November 12, 2024
Time: 18:00 (CET)
Speaker: Dietmar Tamandl (Vienna, Austria)

Description

Dual energy CT (DECT) is an established technique in CT imaging, providing additional spectral information on top of the conventional CT dataset. In this webinar, the viewers will become familiar with the technical requirements of DECT and how it can be used in clinical practice. Special focus will be on oncologic applications, but also non-oncologic topics like fracture assessment, material decomposition and other “benign” indications will be covered.

Furthermore, newer developments in this field are being introduced, which will shape the landscape for spectral imaging in the future.

Learning objectives

To understand the basic priniciples of dual energy CT and its future developments
To learn about the differences of dual energy CT compared to standard single energy CT
To become familiar with clinical applications and potential limitations of this technique 

Webinar 2024.12

Up to date and future perspective of PET/MRI clinical applications

Date: December 10, 2024
Time: 18:00 (CET)
Speaker: Onofrio A. Catalano (Boston, United States)

Description

Join us for a clinically-focused talk exploring the innovative PET/MRI technology, offering an easy-to-understand overview of its unique strengths, weaknesses, opportunities, and challenges. Discover the most significant current and emerging clinical applications, particularly in oncology, that are revolutionizing patient care. We will also review the most relevant clinical literature to highlight key findings and advancements in oncologic PET/MRI.

Learning objectives

PET/MRI is often used as problem solving imaging technology in challenging oncologic cases.
PET/MRI performance is strongly dependent on the specific radiopharmaceuticals, acquisition and reconstruction protocols.
Mastering MRI and nuclear medicine are pivotal for a proficient PET/MR program

Sectral CT in Oncology

Date: January 24, 2023
Time: 18:00 (CEST)
Speaker: Nils Große Hokamp (Cologne, Germany)

Description

The aim of this webinar is to review the basic principles of dual energy computed tomography (DECT) and the available technological approaches to DECT-imaging. Further, available reconstructions from DECT will be discussed with a particular focus towards their application in oncologic imaging.

In the course of this talk, fundamental concepts of spectral CT and image reconstruction will be reviewed. Followed by a case-based review on how which reconstruction can be used in daily operations with a particular scope on oncology. Based on recent studies, future directions and applications of spectral results in oncologic imaging will discussed. As any new technology has its limitations or drawbacks, possible obstacles for technological and diagnostic workflow will be referred. Last, a brief review on the most recent studies will try to give an outlook on current trends in DECT-applications in oncologic patients.

Concluding, the talk will provide guidance on the targeted deployment of spectral in oncologic imaging.

Learning Objectives

• To understand the basic principles and technological approaches to dual energy computed tomograph
• To become familiar with the different reconstructions that can be computed from a dual energy CT acquisition
• To understand how spectral reconstructions can or may impact reporting routine in oncologic imaging now and in future.

About the speaker: Dr. Nils Grosse Hokamp

PD Dr. Nils Grosse Hokamp, PhD, MBA is senior attending radiologist in the Institute for Diagnostic and Interventional Radiology and University Hospital Cologne. He also is appointed lecturer in Experimental Radiology and Radiology at the Medical Faculty of the University of Cologne. His clinical focus lies on abdominal and oncologic imaging and he serves as head of Computed Tomography Research. The University Hospital Cologne was among the first users of Spectral CT in clinical Routine starting May 2016 and based on his early hands-on experience he was invited fellow to Case Western Reserve University in Cleveland, OH, USA for 12 months. His research group now focuses on quantitative imaging biomarkers obtained from spectral detector computed tomography, in particular iodine maps. To date, Dr. Grosse Hokamp has authored and co-authored >100 publications related on Spectral CT.

Assessment of tumoral heterogeneity in imaging

Date: February 13, 2023
Time: 18:00 (CEST)
Speaker: Matthias Frölich (Mannheim, Germany)

Description

In this talk, we will explore the use of imaging techniques for assessing the heterogeneity of tumor lesions, not only in terms of size, shape, but also in terms of lesional texture and interlesional variation. We will examine imaging modalities as well as quantitative image analysis methods and discuss how they can be used to improve diagnosis and treatment planning for cancer patients.

First, the importance of tumoral heterogeneity in resistance to treatment will be discussed. Second, the motivation for addressing tumoral heterogeneity in imaging will be explained. Third, tools and methodology as well as published evidence will be described. Finally, its value proposition for radiologists in the context of the whole treatment process, including interventional treatments, will be examined.

Learning Objectives

• Summarize the concept of tumoral heterogeneity and its importance in oncologic treatment
• Understand the importance of assessing tumoral heterogeneity in imaging for accurate diagnosis and treatment planning for cancer patients.
• Describe the methodology for unraveling tumor heterogeneity in imaging
• Understand the value radiology can provide by quantifying tumor heterogeneity for patients and therapy planning

About the speaker: Dr. Matthias Frölich

• Clinician Scientist at Department of Radiology and Nuclear Medicine in University Medical Center Mannheim
• Head of Research Group: Quantitative Imaging Markers with focus on Computed Tomography

Hybrid Imaging in hematologic malignancies

Date: March 07, 2023
Time: 18:00 (CEST)
Speaker: Clemens Cyran (Munich, Germany)

Response Assessment in Lymphoma – The Role of Morphologic and Metabolic Imaging

Date: April 06, 2023
Time: 18:00 (CEST)
Speaker: Wolfgang Kunz (Munich, Germany)

Metabolic Imaging with MRI

Date: May 15, 2023
Time: 18:00 (CEST)
Speaker: Ferdia Gallagher (Cambridge, United Kingdom)

PET-CT in Infection and Inflammation

Date: June 19, 2023
Time: 18:00 (CEST)
Speakers: Sikandar Shaikh (Somajiguda, Indian)

Quo Vadis, Theranostics 

Date: September 09, 2023
Time: 18:00 (CEST)
Speakers: Jose L. Vercher Conejero (Barcelona, Spain)

Imaging and Biopsy Biomarkers to Promote Cancer Nanomedicine Clinical Translation 

Date: September 19, 2023
Time: 18:00 (CEST)
Speakers: Twan Lammers (Aachen, Germany)

FAPI PET imaging in uro-oncology 

Date: October 09, 2023
Time: 18:00 (CEST)
Speakers: Lena Unterrainer (Munich, Germany)

FAPI PET imaging in uro-oncology 

Date: October 09, 2023
Time: 18:00 (CEST)
Speakers: Lena Unterrainer (Munich, Germany)

Concepts for translation imaging with machine learning

Date: November 23, 2023
Time: 18:00 (CET)
Speakers: Salvador Guillermo Castaneda Vega

Economic aspects in hybrid-imaging

Date: December 11, 2023
Time: 18:00 (CET)
Speakers: Felix Gerhard Gassert (Munich, Germany)